Evexia Lifecare shares closed at 2.61 on March 10, 2025 (BSE) and has given -24.57% returns over the last 6 months and 21.96% over last 12 months. Reported Consolidated quarterly numbers are: Net Sales at Rs 21.70 crore in December 2024 up 214.33% from Rs. 6.90crore in December 2023. EBITDA stands at Rs. 0.27 crore in January 2024 up 237.5% from 0.08crore. Evexia Lifemare EPS has increased to Rs.0.00 in December 24th 2024 from £0.01 in December 23rd. The company has a market capitalization of £1.1 billion. It has a shareholding of £2.2 billion and a market value of £3.4 billion. Its shares are traded on the BSE and the NSE with a trading volume of 2.2 million shares. The stock is traded on a NSE-listed exchange and has a trading value of $1.3 billion.